Ultralife (NASDAQ:ULBI) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Ultralife (NASDAQ:ULBIGet Rating) in a report released on Monday. The firm issued a strong-buy rating on the technology company’s stock.

Separately, TheStreet cut shares of Ultralife from a c- rating to a d rating in a report on Friday, February 4th.

Ultralife stock opened at $5.12 on Monday. Ultralife has a 12 month low of $4.24 and a 12 month high of $11.78. The company has a current ratio of 3.52, a quick ratio of 1.76 and a debt-to-equity ratio of 0.16. The business’s 50 day simple moving average is $5.22 and its 200 day simple moving average is $5.76. The company has a market cap of $82.57 million, a price-to-earnings ratio of -256.00 and a beta of 1.55.

Ultralife (NASDAQ:ULBIGet Rating) last posted its quarterly earnings data on Thursday, February 3rd. The technology company reported ($0.09) EPS for the quarter. Ultralife had a negative net margin of 0.24% and a negative return on equity of 0.32%. The firm had revenue of $23.76 million during the quarter.

In other Ultralife news, Director Bradford T. Whitmore bought 54,900 shares of the stock in a transaction on Thursday, February 24th. The shares were acquired at an average price of $4.44 per share, with a total value of $243,756.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders have acquired a total of 57,930 shares of company stock worth $259,213 in the last three months. Insiders own 39.50% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in ULBI. Marshall Wace North America L.P. bought a new position in shares of Ultralife in the first quarter worth $36,000. Annex Advisory Services LLC bought a new position in shares of Ultralife in the fourth quarter worth $89,000. Millennium Management LLC bought a new position in shares of Ultralife in the second quarter worth $653,000. BlackRock Inc. increased its stake in Ultralife by 6.5% in the fourth quarter. BlackRock Inc. now owns 153,345 shares of the technology company’s stock valued at $926,000 after acquiring an additional 9,303 shares during the last quarter. Finally, Geode Capital Management LLC increased its stake in Ultralife by 10.0% in the third quarter. Geode Capital Management LLC now owns 161,535 shares of the technology company’s stock valued at $1,142,000 after acquiring an additional 14,731 shares during the last quarter. 30.09% of the stock is currently owned by hedge funds and other institutional investors.

Ultralife Company Profile (Get Rating)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Featured Stories

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.